港股午評:止跌反彈!恆指漲1.06%,生物醫藥類股全線爆發,三桶油同步拉昇
連續下跌的港股迎來反彈行情,恆生科技指數一馬當先,午間收漲1.8%,恆生指數、國企指數分別上漲1.06%及1.11%,市場情緒有所回暖。盤面上,作爲市場方向標的大型科技股全線上漲,快手、網易漲近4%,騰訊、阿里巴巴、美團漲2.5%,京東漲1.6%,小米漲約1%,此前自高位回落達17%;受多重消息影響,生物醫藥類股迎來大爆發行情,康方生物大漲超16%,信達生物、君實生物、百濟神州皆走強;連續下跌的核電股迎來反彈,國際油價大漲,三桶油同步拉昇,煤炭股、濠賭股、鋼鐵股、中資券商股、餐飲股紛紛上漲。另一方面,昨日逆勢走強的家電股走低,高鐵基建股繼續昨日下跌行情,中國中車續跌近4%,內銀股、半導體股部分下跌,權重股中芯國際跌近1%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.